Compound 2
(N-(2,5-dihydroxybenzyl)-N,N‘,N’-tris(2-pyridinylmethyl)-1,2-ethanediamine)-triflatozinc(II) triflate
From: Superoxide dismutase activity enabled by a redox-active ligand rather than metal
View in PubChem | MDL Molfile | Chemdraw file
- [Zn(H2qtp1)(OTf)](OTf)
Compound data: ESI-MS
Compound data: 1H NMR
Compound data: 13C NMR
Compound data: 19F NMR
Compound data: IR
Compound data: Crystallographic data
Synthetic procedure: See article for the definitive version of this procedure and for full experimental details.
The H2qtp1 ligand (150 mg, 0.33 mmol) and Zn(OTf)2 (120 mg, 0.33 mmol) were dissolved in 2 mL of MeCN under N2. The solution was stirred for 16 h at room temperature. The subsequent addition of ether to the reaction mixture deposited the product as a colorless crystalline solid (250 mg, 92% yield). These crystals were suitable for single crystal X-ray diffraction. 1H NMR (400 MHz, CD3CN, 293 K): δ 8.72 (d, 1H, J = 4.8 Hz,), 8.37 (d, J = 4.8 Hz, 1H), 8.03-8.13 (m, 4 H), 7.48-7.63 (m, 6H), 7.30 (br, 1H), 6.73 (s, H), 6.59 (d, J = 1.6 Hz, 2H), 6.49 (t, J = 1.6 Hz, 1H), 4.20-4.49 (m, 5H), 3.63 (t, J = 14.6 Hz, 2H), 3.27-3.37 (m, 1H), 3.11-3.18 (m, 2H), 2.86-2.92 (m, 1H), 2.45-2.49 (m, 1H). 13C NMR (100 MHz, CD3CN, 293 K): δ 157.01, 156.83, 156.55, 151.60, 149.70, 149.40, 148.80, 142.77, 142.68, 142.59, 126.69, 126.63, 125.94, 120.59, 120.56, 117.83, 61.63, 61.11, 58.86, 55.88, 52.94, 52.71. 19F NMR (235 MHz, 50 mM HEPES in H2O, 293 K): δ –79.36. MS (ESI): Calcd for [Zn(L-H)]+, 518.1534+, [Zn(L)(OTf)]+, 668.1133; Found, 518.1513, 668.1263. IR (KBr, cm-1): 3443 (s), 1608 (s), 1579 (m), 1489 (w), 1451 (m), 1384 (w), 1353 (w), 1288 (s), 1258 (s), 1234 (s), 1173 (s), 1158 (s), 1109 (w), 1062 (w), 1056 (w), 1031 (s), 971 (w), 822 (w), 762 (m), 639 (s), 573 (w), 517 (m), 490 (w), 417 (w). Elemental Analysis: Calcd for C29H29N5F6O8S2Zn•0.5CH3CN•0.5Et2O: C, 43.84%; H, 4.08%; N, 8.79%; Found: C, 43.99 %; H, 4.10%; N, 8.65%. UV/Vis (MeCN): 295 nm (ε = 3090 M-1 cm-1), 261 nm (ε = 8770 M-1 cm-1).